| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Chen,Yan-Wen | Chairman | 7.36% | |
| Zhang,Yong | Director | 11.87% | |
| Zhao,Wen-Yu | Director | 6.59% | TASHEH BIOTECH CO., LTD. |
| Zhong,Zheng-Feng | Director | 6.36% | |
| Lian,Cheng-Qi | Director | 0.00% | |
| Lv,Zhi-Yuan | Independent Director | 0.00% | |
| Sun,Wei-Yun | Independent Director | 0.00% | |
| Jian,Shao-Feng | Independent Director | 0.00% | |
| Guo,Xiu-Juan | Independent Director | 0.00% |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 33,576 | 125,268 | 137,442 |
| Operating cost | 17,396 | 118,745 | 78,777 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 16,180 | 6,523 | 58,665 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 16,180 | 6,523 | 58,665 |
| Operating expenses | 29,628 | 56,926 | 51,427 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -13,448 | -50,403 | 7,238 |
| Non-operating income and expenses | 1,193 | -4,024 | 9,701 |
| Net profit (loss) before tax | -12,255 | -54,427 | 16,939 |
| Income tax expense (benefits) | 164 | -2,832 | 405 |
| Net profit (loss) of ongoing business for the current period | -12,419 | -51,595 | 16,534 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -12,419 | -51,595 | 16,534 |
| Other comprehensive profit (loss), net | - | -272 | -1 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -12,419 | -51,867 | 16,533 |
| Net profit (loss) attributable to owners of parent company | - | - | - |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | -3 | 1 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | - | - | - |
| Net cash inflows (outflows) from investing activities | - | - | - |
| Net cash inflow (outflow) from financing activities | - | - | - |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
| Beginning balance of cash and cash equivalents | - | - | - |
| Ending balance of cash and cash equivalents | - | - | - |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 135,868 | 154,655 | 201,260 |
| Non-current asset | 105,134 | 110,857 | 119,240 |
| Total asset | 241,002 | 265,512 | 320,500 |
| Current liability | 31,296 | 39,893 | 34,663 |
| Non-current liability | 40,964 | 44,458 | 52,809 |
| Total liability | 72,260 | 84,351 | 87,472 |
| share capital | 142,300 | 142,300 | 142,300 |
| Equity - secruity token | - | - | - |
| capital reserve | 38,861 | 177,826 | 177,826 |
| retained earning | -12,419 | -138,965 | -87,098 |
| Other equity | - | 0 | 0 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | - | - | - |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 168,742 | 181,161 | 233,028 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 11 | 12 | 16 |
